
Elastomeric Infusion Pump Market Report 2026
Global Outlook – By Product Type (Continuous Rate Pumps, Variable Rate Pumps, Patient Controlled Analgesia Pumps), By Flow Rate (Milliliters Per Hour) (Less Than 2 Milliliters Per Hour, 2 To 5 Milliliters Per Hour, Greater Than 5 Milliliters Per Hour), By Distribution Channel (Direct Sales, Distributors And Wholesalers, Online Sales Channels), By Application (Pain Management, Antibiotic Or Antimicrobial Therapy, Chemotherapy, Chelation Therapy, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Home Healthcare Settings, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Elastomeric Infusion Pump Market Overview
• Elastomeric Infusion Pump market size has reached to $1.47 billion in 2025 • Expected to grow to $2.11 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Rising Prevalence Of Chronic Pain Conditions Driving Growth Of The Market Due To Aging Population And Increasing Musculoskeletal Disorders • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Elastomeric Infusion Pump Market?
An elastomeric infusion pump is a lightweight, disposable medical device designed to deliver fluids at a controlled and continuous flow rate through elastic pressure generated by a balloon-like reservoir. It operates without electricity or batteries, making it portable, simple to use, and suitable for convenient fluid administration. The main product types of elastomeric infusion pump include continuous rate pumps, variable rate pumps, and patient controlled analgesia pumps. Continuous rate pumps refer to portable infusion devices designed to deliver medication at a steady flow rate without external power sources. These pumps are categorized by flow rate (milliliters per hour) including less than 2 milliliters per hour, 2 to 5 milliliters per hour, and greater than 5 milliliters per hour and are distributed through direct sales, distributors and wholesalers, and online sales channels. They find application in pain management, antibiotic or antimicrobial therapy, chemotherapy, chelation therapy, and others, serving end users including hospitals, ambulatory surgical centers, home healthcare settings, and others.
What Is The Elastomeric Infusion Pump Market Size and Share 2026?
The elastomeric infusion pump market size has grown strongly in recent years. It will grow from $1.47 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases requiring long-term infusion therapy, growth in hospital-based intravenous treatment procedures, rising adoption of disposable medical devices for infection control, expansion of oncology and pain management treatments, increasing demand for cost-effective drug delivery systems in healthcare facilities.What Is The Elastomeric Infusion Pump Market Growth Forecast?
The elastomeric infusion pump market size is expected to see strong growth in the next few years. It will grow to $2.11 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing shift toward home healthcare and outpatient infusion therapy, increasing demand for patient-centric and portable drug delivery systems, rising focus on reducing hospital stay duration and healthcare costs, expansion of personalized medicine and targeted drug delivery, increasing adoption of minimally invasive and controlled infusion technologies. Major trends in the forecast period include increasing adoption of smart drug delivery monitoring systems integrated with patient data platforms, rising demand for personalized infusion therapy solutions in oncology and pain management, growing use of biodegradable and eco-friendly elastomeric pump materials, increasing preference for home-based infusion therapies supported by portable drug delivery devices, rising integration of cloud-based patient monitoring for infusion therapy adherence tracking.Global Elastomeric Infusion Pump Market Segmentation
1) By Product Type: Continuous Rate Pumps; Variable Rate Pumps; Patient Controlled Analgesia Pumps 2) By Flow Rate (Milliliters Per Hour): Less Than 2 Milliliters Per Hour; 2 To 5 Milliliters Per Hour; Greater Than 5 Milliliters Per Hour 3) By Distribution Channel: Direct Sales; Distributors And Wholesalers; Online Sales Channels 4) By Application: Pain Management; Antibiotic Or Antimicrobial Therapy; Chemotherapy; Chelation Therapy; Other Applications 5) By End User: Hospitals; Ambulatory Surgical Centers; Home Healthcare Settings; Other End Users Subsegments: 1) By Continuous Rate Pumps: Single Rate Continuous Pumps; Fixed Flow Elastomeric Pumps; Long Duration Continuous Infusion Pumps 2) By Variable Rate Pumps: Adjustable Flow Elastomeric Pumps; Multi Rate Infusion Pumps; Programmable Flow Elastomeric Pumps 3) By Patient Controlled Analgesia Pumps: Bolus Dose Controlled Pumps; Lockout Interval Analgesia Pumps; Combination Continuous And Bolus PumpsWhat Are The Drivers Of The Elastomeric Infusion Pump Market?
The rising prevalence of chronic pain conditions is expected to propel the growth of the elastomeric infusion pump market going forward. Chronic pain conditions are disorders that cause persistent or recurring pain lasting longer than three months and can affect daily functioning and quality of life. Chronic pain conditions are increasing due to the rising aging population, as older individuals are more prone to developing long-term pain from age-related musculoskeletal and nerve disorders. Elastomeric infusion pumps help manage chronic pain conditions by continuously delivering controlled doses of pain-relief medication, improving long-term pain control and patient convenience. For instance, in February 2025, according to Arthritis Australia, an Australia-based nonprofit organization, approximately 5.39 million Australians will be living with arthritis, representing a 31% increase since 2025. Therefore, the rising prevalence of chronic pain conditions is driving the growth of the elastomeric infusion pump industry. The increasing demand for home-based and ambulatory healthcare services is expected to propel the growth of the elastomeric infusion pump market going forward. Home-based and ambulatory healthcare services are healthcare services provided outside inpatient hospital settings, including medical care delivered at home and outpatient treatments or procedures performed without hospital admission. The increasing demand for home-based and ambulatory healthcare services is driven by the rising need for cost-effective healthcare solutions, as these services reduce hospital stays, lower treatment expenses, and provide convenient patient care in outpatient or home settings. Elastomeric infusion pumps support home-based and ambulatory healthcare services by enabling portable, continuous medication delivery outside hospitals, allowing patients to receive safe and convenient treatment while maintaining mobility and reducing hospital visits. For instance, in November 2023, according to the Department of Health and Aged Care, an Australia-based central government, as of 2023, 277,612 people had access to a Home Care Package (HCP), marking a 17% increase (40,684 more people) compared to 2022, when 236,928 individuals had access. Therefore, the increasing demand for home-based and ambulatory healthcare services is driving the growth of the elastomeric infusion pump industry. The rising healthcare expenditure is expected to propel the growth of the elastomeric infusion pump market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Increasing healthcare expenditure helps drive the growth of the elastomeric infusion pump by enabling greater investment in advanced, cost-effective infusion technologies for hospital, ambulatory, and home-based patient care. For instance, in April 2025, according to the Office for National Statistics, a UK-based independent producer of official statistics, in 2024, the UK’s healthcare spending reached around $370.71 billion (£317 billion), reflecting a 6.5% nominal increase compared with 2023. Therefore, the rising healthcare expenditure is driving the growth of the elastomeric infusion pump industry.Key Players In The Global Elastomeric Infusion Pump Market
Major companies operating in the elastomeric infusion pump market are Baxter International Inc; B. Braun Melsungen AG; Fresenius Kabi AG; Avanos Medical Inc.; Nipro Corporation; ICU Medical Inc; Vygon Group; Leventon S.A.U.; Ace Medical Co. Ltd.; Pfm Medical AG; Daiken Medical Co. Ltd.; Woo Young Medical Co. Ltd.; Promecon Medical GmbH And Co. KG; Epic Medical Pte Ltd.; Spirit Medical Ltd.; Heka s.r.l.; Mais India; S&S Med Co. Ltd.; Terumo Corporation; Medline IndustriesRegional Outlook
North America was the largest region in the elastomeric infusion pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Elastomeric Infusion Pump Market?
An elastomeric infusion pump market consists of sales of multi-day infusion pumps, ambulatory infusion pumps, and disposable infusion pumps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Elastomeric Infusion Pump Market Report 2026?
The elastomeric infusion pump market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the elastomeric infusion pump industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Elastomeric Infusion Pump Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.58 billion |
| Revenue Forecast In 2030 | $2.11 billion |
| Growth Rate | CAGR of 7.4% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Flow Rate (Milliliters Per Hour), Distribution Channel, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Baxter International Inc; B. Braun Melsungen AG; Fresenius Kabi AG; Avanos Medical Inc.; Nipro Corporation; ICU Medical Inc; Vygon Group; Leventon S.A.U.; Ace Medical Co. Ltd.; Pfm Medical AG; Daiken Medical Co. Ltd.; Woo Young Medical Co. Ltd.; Promecon Medical GmbH And Co. KG; Epic Medical Pte Ltd.; Spirit Medical Ltd.; Heka s.r.l.; Mais India; S&S Med Co. Ltd.; Terumo Corporation; Medline Industries |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
